TOKYO (Reuters) – Johnson & Johnson said on Monday it has filed for regulatory approval of its one-shot COVID-19 vaccine in Japan, and that it can begin supplying doses to the country in early 2022 once it wins approval.
Japan has vaccinated less than 5% of its population, the slowest vaccination pace among the world’s larger, richer countries.
(Reporting by Ritsuko Ando; Editing by Tom Hogue)
